JP3502420B2 - Animal cell culture medium - Google Patents

Animal cell culture medium

Info

Publication number
JP3502420B2
JP3502420B2 JP23540193A JP23540193A JP3502420B2 JP 3502420 B2 JP3502420 B2 JP 3502420B2 JP 23540193 A JP23540193 A JP 23540193A JP 23540193 A JP23540193 A JP 23540193A JP 3502420 B2 JP3502420 B2 JP 3502420B2
Authority
JP
Japan
Prior art keywords
medium
fcs
heme iron
added
iron composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP23540193A
Other languages
Japanese (ja)
Other versions
JPH06269283A (en
Inventor
庸正 梶原
和宏 高橋
正義 難波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Pharmaceutical Co Ltd
Original Assignee
Nihon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Pharmaceutical Co Ltd filed Critical Nihon Pharmaceutical Co Ltd
Priority to JP23540193A priority Critical patent/JP3502420B2/en
Publication of JPH06269283A publication Critical patent/JPH06269283A/en
Application granted granted Critical
Publication of JP3502420B2 publication Critical patent/JP3502420B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は動物細胞を培養するため
の培地に関する。
FIELD OF THE INVENTION The present invention relates to a medium for culturing animal cells.

【0002】[0002]

【従来の技術】動物細胞の培養には、従来市販の基礎培
地に培地の有効成分として血清、例えば、牛胎児血清
(FCS)を2〜20%添加し用いられているが、これ
らの血清が非常に高価であること、血清の性状にロット
差があること、また培養後、培養生産物から血清由来物
質を除去することが面倒であることなどの問題を含んで
いる。
2. Description of the Related Art For culturing animal cells, serum, for example, fetal calf serum (FCS) is added to a commercially available basal medium in an amount of 2 to 20% as an active ingredient of the medium, and these sera are used. It involves problems such as being extremely expensive, having different lots of serum properties, and cumbersome to remove serum-derived substances from the culture product after culturing.

【0003】一方、血清を含まない無血清培地として血
清の添加のかわりにアルブミン、トランスフェリン、イ
ンシュリン等のタンパク成分を添加する方法が一般に用
いられており、商業的にもこのような無血清培地が入手
可能となっている。しかしながら、この無血清培地も必
須成分であるトランスフェリンの価格が高く、より廉価
で且つ有効な培地成分が望まれている。
On the other hand, as a serum-free medium containing no serum, a method of adding protein components such as albumin, transferrin, insulin, etc. in place of the addition of serum is generally used, and such a serum-free medium is commercially available. It is available. However, the cost of transferrin, which is an essential component of this serum-free medium, is high, and a more inexpensive and effective medium component is desired.

【0004】[0004]

【発明が解決しようとする課題】本発明者らはFCSを
添加した培地及びトランスフェリンを必須成分とする無
血清培地と同等以上の細胞培養性能を有し、且つ工業的
にも容易に用いることのできる廉価な細胞培養培地を鋭
意検討した。具体的には 細胞培養培地の細胞増殖力を劣らすことなく、FCS
の添加量を少なくすること 無血清培地として、細胞増殖力を劣らすことなく高価
なトランスフェリンに代わるもの の2面より検討を進めた。即ち、FCS添加量を少なく
することができれば、当然価格面でメリットが出てくる
と共に、血清由来物質も少なくなり、FCSを使用する
培地の問題点が解決できる。又、無血清培地中のトラン
スフェリンは細胞培養培地における役割と性能は認めら
れているものの非常に高価であり、FCSの価格面での
問題を解決するものではない。従って、トランスフェリ
ンに代わる低価格の物質があれば、工業的にも大きな利
益をもたらすことになる。
DISCLOSURE OF THE INVENTION The present inventors have a cell culture performance equal to or higher than that of a medium containing FCS and a serum-free medium containing transferrin as an essential component, and can be easily used industrially. We have earnestly studied the possible inexpensive cell culture medium. Specifically, without compromising the cell growth ability of the cell culture medium, FCS
In order to replace the expensive transferrin without deteriorating the cell growth ability as a serum-free medium, the study was carried out from two aspects. That is, if the amount of FCS added can be reduced, naturally there will be merit in terms of price and the amount of substances derived from serum will be reduced, so that the problems of the medium using FCS can be solved. Further, transferrin in serum-free medium is very expensive although its role and performance in cell culture medium are recognized, and it does not solve the problem in terms of FCS price. Therefore, if there is a low-cost substance that replaces transferrin, it will bring a great industrial advantage.

【0005】[0005]

【課題を解決するための手段】上記の観点に立ち鋭意検
討を重ねた結果、本発明者らはヘモグロビンからそのグ
ロビン鎖の一部を酵素処理により除去したヘム鉄組成物
を配合することにより、FCSを添加する細胞培養培地
においてはFCS添加量を著しく少なくしながら、培地
の細胞増殖力を維持できること及びFCSを含まない無
血清培地にトランスフェリンの代わりにヘム鉄組成物を
配合することにより従来のFCS添加培地及びトランス
フェリンを含む無血清培地と同等の効果が得られること
を見いだした。
Means for Solving the Problems As a result of intensive studies based on the above viewpoints, the present inventors have added a heme iron composition obtained by removing a part of the globin chain from hemoglobin by enzymatic treatment, In a cell culture medium to which FCS is added, the cell growth ability of the medium can be maintained while significantly reducing the amount of FCS to be added, and by adding a heme iron composition in place of transferrin to a serum-free medium containing no FCS, the conventional It was found that an effect equivalent to that of the FCS-added medium and the serum-free medium containing transferrin can be obtained.

【0006】本発明はこの発見に基づくもので、ヘモグ
ロビンからグロビン鎖を一部除去して得られるヘム鉄組
成物を配合してなる動物細胞培養用培地である。
The present invention is based on this finding, and is an animal cell culture medium containing a heme iron composition obtained by partially removing a globin chain from hemoglobin.

【0007】本発明で用いるヘム鉄組成物とはヘモグロ
ビンに酵素(プロテアーゼ)を作用させてグロビン鎖の
一部をヘモグロビンから除去したもので、等電点で沈澱
させたり、限外濾過して濾液を採るなどの手段により濃
縮した製品がヘム鉄の一般名で市販(ヘムロンR ;伊藤
ハム(株),ヘムエースR ;旭化成工業(株),水溶性
ヘムロンR ;有明食品化工販売(株),Hem Fe
ST−PR ;一丸フアルコス(株),Hem ST−P
R ;三菱化成食品(株)、等)され、鉄欠乏症に投与
されている。その性状は次のとおりである。
The heme iron composition used in the present invention is a hemoglobin obtained by causing an enzyme (protease) to act on hemoglobin to remove a part of the globin chain from hemoglobin. The hemoglobin is precipitated at the isoelectric point or is filtrated by ultrafiltration. The product concentrated by means such as collecting is marketed under the general name of heme iron (Hemron R ; Itoham Co., Ltd., Hem Ace R ; Asahi Kasei Kogyo Co., Ltd., Water-soluble Hemron R ; Ariake Food Chemical Co., Ltd., Hem Fe
ST-P R ; Ichimaru Farukos Co., Ltd., Hem ST-P
F R; Mitsubishi Kasei Foods Co., etc) is, and is administered in iron deficiency. Its properties are as follows.

【0008】外観は黒褐色、鉄含量0.5〜2.5%、
pH3.0以下および6.0以上で高い水溶性を示し、
水溶液は121℃、30分の加熱に安定であり、鉄はヘ
ム−プロトポルフィリンの2価鉄錯塩として存在してお
り、分子量は500から12,000の範囲に分布する
が、主要有効成分は10,000前後である。
The appearance is blackish brown, the iron content is 0.5 to 2.5%,
Shows high water solubility at pH 3.0 or below and 6.0 or above,
The aqueous solution is stable to heating at 121 ° C. for 30 minutes, iron exists as a divalent iron complex salt of heme-protoporphyrin, and the molecular weight is distributed in the range of 500 to 12,000, but the main active ingredient is 10 It is around 1,000.

【0009】ヘモグロビンは豚以外の動物、たとえば牛
や馬由来のものでもよく、錯塩中の鉄は酸化により3価
となっていてもよい。
Hemoglobin may be derived from animals other than pigs, such as cows and horses, and the iron in the complex salt may be trivalent due to oxidation.

【0010】ヘム鉄組成物の配合量は、鉄濃度として
0.001−1μg/mlが好ましく、さらに好ましく
は0.005−0.1μg/mlである。ヘム鉄組成物
は動物細胞培養用の基礎培地に配合するのが便宜である
が、基礎培地としては、市販のたとえば、Eagle
MEM培地、DULBECCO’S MEM培地、RP
MI 1640培地、L 15培地、RDP培地等が一
般に用いられるが、特に限定されるものではない。
The content of the heme iron composition is preferably 0.001-1 μg / ml, more preferably 0.005-0.1 μg / ml as an iron concentration. The heme iron composition is conveniently added to a basal medium for animal cell culture, and the basal medium is commercially available, for example, Eagle.
MEM medium, DULBECCO'S MEM medium, RP
MI 1640 medium, L 15 medium, RDP medium and the like are generally used, but are not particularly limited.

【0011】従来、FCSは基礎培地に2〜20%添加
されるが、FCSを10%添加した培地にヘム鉄組成物
を微量添加するとコロニー形成率はFCSのみ添加した
ものに比べて、大幅に増加する(図1、実施例1)。
Conventionally, FCS is added to the basal medium in an amount of 2 to 20%. However, when a trace amount of the heme iron composition is added to the medium containing 10% of FCS, the colony forming rate is significantly higher than that of the medium containing only FCS. Increase (FIG. 1, Example 1).

【0012】また、FCSのみを0.1%添加した培地
においてはコロニー形成が認められないが、ヘム鉄組成
物を追加添加したものではFCS10%添加の培地とほ
ぼ同等のコロニー形成率を示す(実施例1)。
No colony formation was observed in the medium supplemented with FCS alone at 0.1%, but the colony formation rate substantially equal to that of the medium supplemented with 10% FCS in the medium supplemented with the heme iron composition ( Example 1).

【0013】トランスフェリンとヘム鉄組成物の細胞増
殖力の比較したところ、FCSを含まない、無血清培地
では、ヘム鉄組成物の添加はコロニー形成率においてト
ランスフェリンよりも優れ、FCSを10%添加した培
地では、ヘム鉄組成物は増殖力を有意に増加するが、ト
ランスフェリンは増殖力に影響を与えない(図2、実施
例2)。
[0013] When comparing the cell growth potentials of transferrin and heme iron composition, in the serum-free medium containing no FCS, the addition of the heme iron composition was superior to transferrin in terms of colony forming rate, and 10% of FCS was added. In the medium, the heme iron composition significantly increases the viability, while transferrin does not affect the viability (Fig. 2, Example 2).

【0014】[0014]

【実施例】以下に実施例の形で本発明をさらに説明す
る。
The present invention will be further described below in the form of examples.

【0015】実施例1 標準培地に本発明のヘム鉄組成物または牛胎児血清(F
CS)を添加した場合と無添加の場合、および両者を併
用した場合の細胞増殖効果を比較検討した。
Example 1 A heme iron composition of the present invention or fetal bovine serum (F
The cell proliferation effect was compared between the case of adding CS), the case of not adding CS, and the case of using both in combination.

【0016】細胞としてHela細胞を用い、基礎培地
としては市販のEagle’s MEM培地を用い、そ
の1Lに対してL−アラニン8.8mg、L−アスパラ
ギン・1水和物15.0mg、L−アスパラギン酸1
3.3mg、L−グルタミン酸14.7mg、L−プロ
リン11.5mg、L−セリン10.5mg、グリシン
7.5mg、L−グルタミン0.292g、デキサメタ
ソン0.1μM、亜セレン酸ナトリウム0.1μMおよ
びインシュリン1mgを加えたものを標準培地とした。
Hela cells were used as cells, and a commercially available Eagle's MEM medium was used as a basal medium. L-alanine 8.8 mg, L-asparagine monohydrate 15.0 mg, L- Aspartic acid 1
3.3 mg, L-glutamic acid 14.7 mg, L-proline 11.5 mg, L-serine 10.5 mg, glycine 7.5 mg, L-glutamine 0.292 g, dexamethasone 0.1 μM, sodium selenite 0.1 μM and The standard medium was prepared by adding 1 mg of insulin.

【0017】この標準培地またはこれにFCSを0.1
%および10%添加したものそれぞれにヘム鉄組成物を
鉄濃度として0.005μg/ml、0.01μg/m
lおよび0.1μg/mlになるように添加した培地を
用いて以下の培養を行った。
This standard medium or FCS to this standard medium
% And 10% added to the heme iron composition as iron concentrations of 0.005 μg / ml and 0.01 μg / m, respectively.
The following culture was carried out using a medium added so that the concentration became 1 and 0.1 μg / ml.

【0018】各培地5mlずつを入れた径60mmのプ
ラスチックシャーレにトリプシン処理したのちPBSバ
ッファーで洗浄したHeLa細胞を500個ずつ接種
し、37℃、5%CO2 の条件下で7〜10日間インキ
ュベートし、次いでメタノールを加えて固定し、ギムザ
染色液にて染色し、コロニーをカウントした。コロニー
形成率を求める計算式は次のとおりである。
A plastic dish with a diameter of 60 mm containing 5 ml of each medium was trypsinized and inoculated with 500 HeLa cells washed with PBS buffer and incubated at 37 ° C. under 5% CO 2 for 7 to 10 days. Then, methanol was added to fix the cells, and the cells were stained with Giemsa staining solution and the colonies were counted. The calculation formula for obtaining the colony formation rate is as follows.

【0019】 コロニー形成率=コロニー形成数/接種細胞数×100 この結果を表1および図1に示す。[0019] Colony formation rate = number of colonies formed / number of inoculated cells x 100 The results are shown in Table 1 and FIG.

【0020】[0020]

【表1】 [Table 1]

【0021】表1から明らかなように、FCS添加培地
に本発明のヘム鉄組成物を添加すると細胞増殖が著しく
促進され、またFCS無添加の、すなわち無血清培地に
おいてもヘム鉄組成物を鉄濃度として0.1μg/ml
添加するとFCS添加とほぼ同等の細胞増殖効果を現わ
す。
As is clear from Table 1, when the heme iron composition of the present invention is added to the FCS-added medium, cell growth is significantly promoted, and the heme iron composition is added to the FCS-free medium, that is, in the serum-free medium. 0.1 μg / ml as concentration
When added, a cell proliferation effect almost equal to that of FCS addition is exhibited.

【0022】実施例2 トランスフェリンとヘム鉄組成物の細胞増殖効果を比較
し、同時にFCS添加培地に対するトランスフェリン添
加の効果の有無を検討した。
Example 2 The cell growth effects of transferrin and heme iron compositions were compared, and at the same time, the presence or absence of the effect of transferrin addition on the FCS-added medium was examined.

【0023】実施例1と同様にして調製した標準培地ま
たはこれにFCSを10%加えたものそれぞれにヘム鉄
組成物を鉄濃度として0.1μg/ml加えた培地、ト
ランスフェリン1μg/mlを加えた培地、硫酸第一鉄
を鉄濃度で0.1μg/ml加えた培地を準備し、これ
らの培地にHeLa細胞を実施例1と同様に培養してコ
ロニー形成率を求めた。結果を表2および図2に示す。
A standard medium prepared in the same manner as in Example 1 or a medium obtained by adding 10% of FCS to each medium was added with a medium containing 0.1 μg / ml of heme iron composition as an iron concentration, and 1 μg / ml of transferrin. A medium was prepared by adding ferrous sulfate at an iron concentration of 0.1 μg / ml, and HeLa cells were cultured in these media in the same manner as in Example 1 to determine the colony formation rate. The results are shown in Table 2 and FIG.

【0024】[0024]

【表2】 [Table 2]

【0025】表2から明らかなように、本発明のヘム鉄
組成物は無血清培地成分として、トランスフェリンより
遙かに強い細胞増殖効果を示し、またトランスフェリン
10%にFCSを含む培地を使用する場合には細胞増殖
効果に影響を与えないことが認められる。
As is clear from Table 2, the heme iron composition of the present invention shows a much stronger cell growth effect than transferrin as a serum-free medium component, and when a medium containing FCS in 10% transferrin is used. It is observed that does not affect the cell growth effect.

【0026】実施例3 標準培地に本発明のヘム鉄組成物および牛胎児血清(F
CS)を添加した場合とヘム鉄無添加の場合の細胞増殖
効果を比較検討した。
Example 3 The heme iron composition of the present invention and fetal bovine serum (F
The cell growth effect of the case of adding CS) and the case of adding no heme iron were comparatively examined.

【0027】細胞として、ヒト×ヒトハイブリドーマ細
胞を用い、基礎培地としては市販のEagle’s M
EM培地を用い、その1Lに対してL−アルギニン8.
8mg、L−アスバラギン・1水和物15.0mg、L
−アスバラギン酸13.3mg、L−グルタミン酸1
4.7mg、L−プロリン11.5mg、L−セリン1
0.5mg、グリシン7.5mg、L−グルタミン0.
292g、デキサメタソン0.1μM、亜セレン酸ナト
リウム0.1μM、およびインスリン1mgを加えたも
のを標準培地とした。
Human x human hybridoma cells were used as the cells, and commercially available Eagle's M was used as the basal medium.
Using EM medium, L-arginine 8.
8 mg, L-asparagine monohydrate 15.0 mg, L
-Aspartic acid 13.3 mg, L-glutamic acid 1
4.7 mg, L-proline 11.5 mg, L-serine 1
0.5 mg, glycine 7.5 mg, L-glutamine 0.
A standard medium was prepared by adding 292 g, dexamethasone 0.1 μM, sodium selenite 0.1 μM, and insulin 1 mg.

【0028】この標準培地にFCSを10%添加したも
のを対照として用い、標準培地にFCSを0.1〜5%
添加したものにヘム鉄組成物またはFeSO4 を鉄濃度
で0.1μg/ml添加したものと、添加しない培地を
用いて以下の培養をおこなった。
This standard medium containing 10% FCS was used as a control, and 0.1-5% FCS was added to the standard medium.
The following culture was performed using a heme iron composition or FeSO 4 at an iron concentration of 0.1 μg / ml and a medium to which the heme iron composition was not added.

【0029】各培地1m1ずつをいれた24穴マルチプ
レートに、ヒト×ヒトハイブリドーマ細胞を3万個ずつ
接種し、37℃、5%CO2 の条件下で4日間培養し、
その細胞数をコールターカウンターによりカウントし
た。結果を表3、表4、表5および図3に示す。
30,000 human × human hybridoma cells were inoculated into 24-well multiplates containing 1 ml of each medium and cultured at 37 ° C. under 5% CO 2 for 4 days.
The number of cells was counted by a Coulter counter. The results are shown in Table 3, Table 4, Table 5 and FIG.

【0030】[0030]

【表3】 [Table 3]

【0031】[0031]

【表4】 [Table 4]

【0032】[0032]

【表5】 [Table 5]

【0033】[0033]

【図3】[Figure 3]

【0034】表3〜5および図3から明らかなように、
ヘム鉄添加の場合FCSの添加量を0.5%まで減らし
ても、FCS10%添加培地とほぼ同等の細胞増殖効果
を現す。
As is apparent from Tables 3-5 and FIG.
In the case of adding heme iron, even if the amount of FCS added is reduced to 0.5%, a cell growth effect almost equal to that of a medium containing 10% FCS is exhibited.

【0035】実施例4 標準培地に本発明のヘム鉄組成物を添加した場合とトラ
ンスフェリンを添加した場合の細胞増殖効果を比較検討
した。
Example 4 The cell growth effects of the addition of the heme iron composition of the present invention and the addition of transferrin to a standard medium were compared and examined.

【0036】細胞として、ヒト×ヒトハイブリドーマ細
胞を用い、基礎培地としては市販の、RPMI1640
培地を用い、これに卵黄リポ蛋白0.1μL/ml、亜
セレン酸ナトリウム2.5×10-6M、エタノールアミ
ン0.2mM、およびインスリン2μg/mlを加えた
ものを標準培地とした。
Human x human hybridoma cells were used as cells, and the basal medium was commercially available RPMI1640.
A standard medium was prepared by adding 0.1 μL / ml of egg yolk lipoprotein, 2.5 × 10 −6 M sodium selenite, 0.2 mM of ethanolamine, and 2 μg / ml of insulin to the medium.

【0037】この標準培地にFCSを10%添加したも
のを対照として用い、標準培地にヘム鉄組成物の鉄濃度
を0.01,0.05,0.1および0.2μg/ml
添加したものと、トランスフェリン2μg/ml添加し
た培地を用いて以下の培養をおこなった。
This standard medium supplemented with 10% FCS was used as a control, and the iron concentration of the heme iron composition was 0.01, 0.05, 0.1 and 0.2 μg / ml in the standard medium.
The following culture was performed using the added medium and the medium containing transferrin at 2 μg / ml.

【0038】各培地1m1ずつをいれた24穴マルチプ
レートに、ヒト×ヒトハイブリドーマ細胞を6万個ずつ
接種し、37℃、5%CO2 の条件下で4日間培養し、
その細胞数をコールターカウンターによりカウントし
た。結果を表6および図4に示す。
Into a 24-well multiplate containing 1 ml of each medium, 60,000 human x human hybridoma cells were inoculated and cultured at 37 ° C under 5% CO 2 for 4 days,
The number of cells was counted by a Coulter counter. The results are shown in Table 6 and FIG.

【0039】[0039]

【表6】 [Table 6]

【0040】[0040]

【図4】[Figure 4]

【0041】[0041]

【発明の効果】本発明によれば、FCSを含有する培地
にヘム鉄組成物を微量添加することにより動物細胞増殖
作用を著しく増強することができ、FCSを含有しない
無血清培地にヘム鉄組成物を添加することによりトラン
スフェリン添加と同様の動物細胞増殖効果を得ることが
できる。
INDUSTRIAL APPLICABILITY According to the present invention, by adding a trace amount of the heme iron composition to the FCS-containing medium, it is possible to remarkably enhance the animal cell growth action, and to add serum-free medium containing no FCS to the heme iron composition. By adding the substance, the same animal cell growth effect as that of transferrin can be obtained.

【0042】[0042]

【図面の簡単な説明】[Brief description of drawings]

図1、図2、図3および図4はそれぞれ実施例1、2、
3および4における実験の結果を示すグラフで、図1中
の黒棒は標準培地に各濃度のFCSと本発明のヘム鉄組
成物を0.1μg/mlの鉄濃度になるように添加した
場合のコロニー形成率、白棒は同無添加の場合のコロニ
ー形成率を示す。図2中の黒棒は標準培地にFCSを1
0%添加しまたはしない培地それぞれにつき、ヘム鉄組
成物を鉄濃度として0.1μg/ml添加しトランスフ
ェリンは添加しない場合のコロニー形成率、斜線棒はト
ランスフェリンを1μg/mlと硫酸第一鉄を鉄濃度で
0.1μg/ml加えた場合のコロニー形成率、白棒は
硫酸第一鉄のみを上記の濃度で加えた場合のコロニー形
成率を示す。図3中の白丸は標準培地に鉄を添加しない
場合の黒丸はヘム鉄組成物を鉄濃度で0.1μg/ml
添加した場合の各培養日における増殖細胞数を示す。図
4中の白棒は標準培地にFCSを10%またはトランス
フェリンを2μg/mlの濃度になるように添加した培
地で4日間培養した場合の細胞増殖数、黒棒はヘム鉄組
成物を鉄濃度で0.01,0.05,0.1および0.
2μg/ml加えた培地で同様に培養した場合の細胞増
殖数を示す。
1, FIG. 2, FIG. 3 and FIG.
In the graphs showing the results of the experiments in 3 and 4, the black bars in FIG. 1 represent the case where FCS of each concentration and the heme iron composition of the present invention were added to the standard medium so that the iron concentration was 0.1 μg / ml. The colony formation rate of, and the white bar indicates the colony formation rate in the case of no addition. The black bar in Fig. 2 indicates 1 FCS in the standard medium.
The colony formation rate when 0.1 μg / ml of heme iron composition was added as the iron concentration and transferrin was not added to each medium with or without 0% addition, the shaded bar indicates transferrin at 1 μg / ml and ferrous sulfate as iron. The colony formation rate when 0.1 μg / ml was added at the concentration, and the white bar shows the colony formation rate when only ferrous sulfate was added at the above concentration. The white circles in FIG. 3 are the heme iron compositions in the case where iron was not added to the standard medium, and the iron concentration was 0.1 μg / ml.
The number of proliferating cells on each culture day when added is shown. The white bar in FIG. 4 indicates the cell growth number when cultured for 4 days in a medium containing FCS at a concentration of 10% or transferrin at a concentration of 2 μg / ml in a standard medium, and the black bar indicates the iron concentration of the heme iron composition. At 0.01, 0.05, 0.1 and 0.
The number of cell proliferation when similarly cultured in a medium supplemented with 2 μg / ml is shown.

Claims (5)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ヘモグロビンからグロビン鎖を一部除去
して得られるヘム鉄組成物を配合してなる動物細胞培養
用培地。
1. An animal cell culture medium containing a heme iron composition obtained by partially removing a globin chain from hemoglobin.
【請求項2】 ヘム鉄組成物が鉄濃度として0.001
−1μg/ml配合される請求項1記載の培地。
2. The heme iron composition has an iron concentration of 0.001.
The medium according to claim 1, which is -1 μg / ml.
【請求項3】 培地中に牛胎児血清およびヘム鉄組成物
が配合される請求項1記載の培地。
3. The medium according to claim 1, wherein the medium contains fetal bovine serum and a heme iron composition.
【請求項4】 培地中に約0.1%以上の牛胎児血清お
よび鉄濃度として0.001−1μg/mlのヘム鉄組
成物が配合される請求項1または3記載の培地。
4. The medium according to claim 1, wherein the medium contains about 0.1% or more fetal bovine serum and a heme iron composition having an iron concentration of 0.001-1 μg / ml.
【請求項5】 ヘモグロビンのグロビン鎖を一部除去し
て得られるヘム鉄組成物よりなる動物細胞培養における
動物細胞増殖促進剤。
5. An animal cell growth promoter in animal cell culture, comprising a heme iron composition obtained by partially removing a globin chain of hemoglobin.
JP23540193A 1993-01-21 1993-08-27 Animal cell culture medium Expired - Fee Related JP3502420B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23540193A JP3502420B2 (en) 1993-01-21 1993-08-27 Animal cell culture medium

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2747093 1993-01-21
JP5-27470 1993-01-21
JP23540193A JP3502420B2 (en) 1993-01-21 1993-08-27 Animal cell culture medium

Publications (2)

Publication Number Publication Date
JPH06269283A JPH06269283A (en) 1994-09-27
JP3502420B2 true JP3502420B2 (en) 2004-03-02

Family

ID=26365399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23540193A Expired - Fee Related JP3502420B2 (en) 1993-01-21 1993-08-27 Animal cell culture medium

Country Status (1)

Country Link
JP (1) JP3502420B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE384120T1 (en) * 1999-08-27 2008-02-15 Invitrogen Corp METAL BONDING COMPOUNDS AND THEIR USE IN CELL CULTURE MEDIA COMPOSITIONS
WO2016159177A1 (en) 2015-03-30 2016-10-06 味の素株式会社 Chelated iron-containing culture medium for neural stem cells

Also Published As

Publication number Publication date
JPH06269283A (en) 1994-09-27

Similar Documents

Publication Publication Date Title
USRE30985E (en) Serum-free cell culture media
CN102317440B (en) Improved culture media additive and process for using it
US4205126A (en) Serum-free cell culture media
CN104911143B (en) A kind of no albumen, serum free medium without hydrolysate and preparation method thereof
CN106434526A (en) Non-serum non-animal-origin-additive insect cell culture medium
JP4972261B2 (en) Metal binding compounds and their use in cell culture media compositions
JP3502420B2 (en) Animal cell culture medium
EP0593539A1 (en) Iron chelate culture medium additive
Léry et al. A new serum-free medium for lepidopteran cell culture
Verger et al. Growth‐promoting effects of iron‐and cobalt‐protoporphyrins on cultured embryonic cells
DE4219250A1 (en) Serum-free cell culture medium
CN109536435A (en) A kind of Serum-free and protein-free medium
JPH0331436B2 (en)
Okabe-Kado et al. Effects of histone fractions on induction of differentiation of cultured mouse myeloid leukemia cells
CN110382688A (en) Culture medium comprising N- acyl group-X- glutamine dipeptide
JPH08149975A (en) Composition for tissue colture
FR2846004A1 (en) COMPOSITION FOR CULTIVATION OF CELLS, IN PARTICULAR ANIMAL OR TISSUE, COMPRISING POLYETHYLENE GLYCOL
FI60031B (en) STABILIZED THYMIDE INFOSPHYL PREPARATION FOR ANALYZING VACCINATION WITH BACTERIA
CN109988741B (en) Serum substitute for cell culture, preparation method thereof, serum substitute composition for cell culture and cell culture medium
US20230200424A1 (en) Compositions comprising cys-peptides
Moraes et al. Culture media for animal cells
JP4586181B2 (en) Protein stabilization method, protein stabilizer and protein-containing solution
Sharma et al. A chemically defined medium for the production of staphylococcal beta hemolysin
Nath et al. Threonine dehydratase from goat liver
WO2020187420A1 (en) Complex iron containing culture medium

Legal Events

Date Code Title Description
A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20031205

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071212

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081212

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091212

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101212

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101212

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111212

Year of fee payment: 8

LAPS Cancellation because of no payment of annual fees